APPLICATION BIOIMPEDANCE BODY COMPOSITION МОNITOR (BCM) IN CLINICAL PRACTICE IN DIALYSIS PATIENTS (LITERATURE REVIEW)
https://doi.org/10.24884/1561-6274-2013-17-4-49-57
Abstract
Adequate control of hydration plays an important role in the treatment of dialysis patients. Well known that chronic fluid overload causes hypertension and left ventricular hypertrophy, however dehydration can be associated with intradialysis complications. Hyperhydration and dehydration associated with increased morbidity and mortality in patients on dialysis. The exact definition of the state of hydration in dialysis patients remains a challenge, and is based on clinical criteria and unavailability of accurate measuring instruments. Bioimpedance spectroscopy method determines the state of hydration and body composition, which reliability had been confirmed by isotopic dilution and other reference methods for the determination of body composition.
About the Authors
L. N. Rakhmatullina
Северо-Западный государственный медицинский университет им. И.И.Мечникова
Russian Federation
Russian Federation
K. Y. Gurevich
Fresenius Medical Care
Russian Federation
Russian Federation
References
1. Шишкин АН, Федорова ЮЮ. Интрадиализная гипотония: факторы, ассоциированные с процедурой гемодиализа. Нефрология 2012; 16 (2): 64-68
2. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38 [Suppl 4]: 11-17
3. Ozkahya M, Toz H, Qzerkan E et al. Impact of blood control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660
4. Cocchi R, Degli EE, Fabbri A et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14: 1536–1540
5. Woodrow G, Devine Y, Cullen M, Lindley E. Application of bioelectrical impedance to clinical assessment of body composition in peritoneal dialysis. Perit Dial Int 2007; 27: 496 -502
6. Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 153–158
7. Бовкун ИВ, Румянцев АШ. Оценка тактики проведения сеанса гемодиализа у больных с разной величиной артериального давления. Нефрология 2006; 10 (3): 62-67
8. Новикова НА, Гендлин ГЕ, Сторожаков ГИ и др. Выживаемость больных хронической терминальной почечной недостаточностью, получающих постоянный амбулаторный перитонеальный диализ. Клиническая нефрология 2010; 4: 26-33
9. Machek P, Jirka T, Moissl U et al. Optimal fluid status assessed with bioimpedance spectroscopy reduces IMES and hospitalisation in hemodialysis patients. Nephrol Dial Transplant plus 2008; 1(Suppl 2): 322
10. Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1574–1579
11. Ляшенко ОА, Корнеев АМ, Гуревич КЯ. Коррекция артериальной гипертензии у больных на программном гемодиализе. Врач 2011; 2: 63-66
12. Ates K, Nergizoglu G, Keven K et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: 767–776
13. Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-2957.
14. Menon MK, Naimark DM, Bargman JM et al. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16 (11): 2207–2213.
15. Tonbul Z, Altintepe L, Sözlü C et al. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 2003; 23 (1): 46–52
16. Wong PN, Mak SK, Lo KY et al. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients. Singapore Med J 2004; 45 (11): 520–524
17. Konings CJAM., Kooman JP, Schonck M et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22: 477 – 487
18. Дудко МЮ, Шутов ЕВ, Капитанов ЕН, Ермоленко ВМ. Влияние нарушений водного баланса на состояние сердечнососудистой системы у больных на заместительной почечной терапии. Нефрология и диализ 2006; 8 (3): 244-249
19. Ляшенко ОА, Гуревич КЯ, Корнеев АМ. Клинические, лабораторные и инструментальные характеристики, ассоциированные с артериальной гипертензией у больных, находящихся на программном гемодиализе. Нефрология 2011; 15 (2): 49-56
20. Ветчинникова ОН, Пронина ВП, Агальцов МВ, Кантария РО. Ремоделирование левого желудочка сердца у больных на перитонеальном диализе. Клиническая нефрология 2012; 1: 21-30
21. Sinha AD, Agarwal R. Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial 2009; 22: 480–482
22. Agarwal R, Alborzi P, Satyan S et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500–507
23. Kayikcioglu M, Tumuklu M, Ozkahya M et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 2009; 24: 956–962
24. Wang X, Axelsson J, Lindholm B, Wang T. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients. Blood Purif 2005; 23: 373–378
25. Kutlay S, Dincer I, Sengul S et al. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. Am J Kidney Dis 2006; 47: 485–492
26. Белов ВВ, Ильичева ОЕ. Динамика показателей хронической сердечной недостаточности у больных хронической болезнью почек при почечно-заместительной терапии. Нефрология 2006; 10 (1): 35-39
27. Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol 2003; 93: 94–101
28. D’Amico G, Locatelli F. Hypertension in dialysis: pathophysiology and treatment. J Nephrol 2002; 15: 438–445
29. Levin NW. What clinical insights from the early days of dialysis are being overlooked today? Semin Dial 2005; 18: 13–14
30. Saint-Remy A, Krzesinski JM. Optimal blood pressure level and best measurement procedure in hemodialysis patients. Vasc Health Risk Manag 2005; 1: 235–244
31. Li Z, Lacson E, Lowrie EG, Ofsthun N et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48: 606–615
32. Шутов АМ, Мастыков ВЭ, Едигарова ОМ. Использование допплер-эхокардиографии для уточнения «сухого веса» больного на программном гемодиализе. Нефрология 2004; 8(2): 35-39
33. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66(3):1212-1220
34. Stegmayr BG. Ultrafiltration and Dry Weight – What are the Cardiovascular Effects? Artif Organs 2003; 27(3): 227 – 229
35. Zucchelli P, Santoro A. Dry weight in hemodialysis: volemic control. Semin Nephrol 2001; 3: 286-290
36. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002; 13:1307–1320
37. Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338–2344
38. Asci G, Ozkahya M, Duman S et al. Volume control associated with better cardiac function in longterm peritoneal dialysis patients. Perit Dial Int 2006; 26:85–88
39. Wong PN, Mak SK, Lo KY, Tong GM, Wong AK. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients. Singapore Med J 2004; 45 (11): 520–524
40. Nishimura K, Kamiya Y, Miyamoto K et al. Molecular weight of polydisperse icodextrin effects its oncotic contribution to water transport. J Artif Organs 2008; 11;165-169
41. Lin X, Lin A, Ni Z et al. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant 2010; 25:2322-2327
42. Jansen MA, Termorshuizen F, Korevaar JC et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68:1199-1205
43. Van Biesen W, Verbeke F, Devolder I, Vanholder R. The relation between salt, volume, and hypertension: clinical evidence for forgotten but still valid basic physiology. Perit Dial Int 2008; 28: 596–600
44. Van Biesen W, Williams JD, Covic AC et al. Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study Cohort. PLoS ONE 2011; 6(2): e17148
45. Davison SN, Jhangri GS, Jindal K, Pannu N. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis. Clin J Am Soc Nephrol 2009; 4: 1044–1050
46. Huang WH, Chen KH, Hsu CW et al. Residual renal function – one of the factors associated with arterial stiffness in peritoneal dialysis patients: Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif 2008; 26: 133-137
47. Wang AY. The John F. Maher Award Recipient Lecture 2006. The “heart” of peritoneal dialysis: residual renal function. Perit Dial Int 2007; 27: 116-124
48. Han SH, Lee SC, Ahn SV et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 2007; 22: 2653-2658
49. Chandna SM, Kulinskaya E, Farrington K. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Nephrol Dial Transplant 2005; 20: 2130-2138
50. Van Biesen W, Vanholder R, Veys N, Lameire N. Peritoneal dialysis in anuric patients: concerns and cautions. Semin Dial 2002; 15: 305-310
51. Jansen MAM, Hart AAM, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046–1053
52. Davies SJ, Brown EA, Reigel W et al. What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS. Perit Dial Int 2006; 26: 458–465
53. Wiggins KJ, Rumpsfeld M, Hawley CM, O’Shea A et al. Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion. Nephrology (Carlton) 2007; 12: 218–223
54. Sipahioglu MH, Aybal A, Unal A et al. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years’ experience in a single center. Perit Dial Int 2008; 28(3): 238–245
55. Carmona RA, Fontan PM, Naveiro GR et al. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44:132-145
56. Davenport A, Willicombe M. Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi – frequency bioimpedance. Int J Artif Organs 2009; 32:779-786
57. Pierratos A. Daily nocturnal home hemodialysis. Kidney Int 2004; 65:1975–1986
58. Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23:2965–2971
59. Ozkahya M, Ok E, Toz H et al. Long-termsurvival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006; 21: 3506–3513
60. Fagugli RM, Pasini P, Quintaliani G et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysispatients. Nephrol Dial Transplant 2003;18: 2332–2338
61. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 2007; 298 (11): 1291–1299
62. Davies S, Carlsson O, Simonsen O et al. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant 2009; 24: 1609–1617
63. de Paula FM, Peixoto AJ, Pinto LV et al. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004; 66 [Suppl 3]: 1232–1238
64. Kalantar-Zadeh K, Regidor DL, Kovesdy CP et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119: 671-679
65. Родин И.Н. Инструментальное определение «сухого веса» и оптимального объема ультрафильтрации у больных в условиях лечения программным гемодиализом. Нефрология и диализ 2002; 4(1): 41-44
66. Zhu F, Wystrychowski G, Kitzler T et al. Application of bioimpedance techniques to peritoneal dialysis. Contrib Nephrol 2006; 150: 119–128
67. Devolder I, Verleysen A, Vijt D et al. Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 2010; 30:1-7
68. Мартиросов ЭГ, Николаев ДВ, Руднев СГ. Технологии и методы определения состава тела человека. Наука, М., 2006; 102-127
69. Николаев ДВ, Смирнов АВ, Бобринская ИГ, Руднев СГ. Глава 2. Биоимпеданс и его измерение. В: Биоимпедансный анализ состава тела человека. Наука, М., 2009; 49-89
70. Moissl UM, Wabel P, Chamney PW et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 2006; 27: 921–933
71. Chamney PW, Wabel P, Moissl UM et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007; 85: 80–89
72. Moissl U, Bosaeus I, Lemmey A et al. Validation of a 3C model for determination of body fat mass. J Am Soc Nephrol 2007; 18 A: 257
73. Moissl U, Wabel P, Chamney PW et al. Validation of a bio impedance spectroscopy method for the assessment of fat free mass. NDT Plus 2008; 1(Suppl 2): 215
74. Wabel P, Chamney PW, Moissl U et al. Reproducibility of bioimpedance spectroscopy (BIS) in health and disease (abstract). Nephrol Dial Transplant 2007; 22 [Suppl 6]: 137
75. Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif 2009; 27: 75-80
76. Passauer J, Miller H, Schleser A et al. Evaluation of clinical dry weight assessment in haemodialysis patients by bioimpedance spectroscopy. J Am Soc Nephrol 2007; 18 A: 256
77. Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. Contrib Nephrol 2008; 161: 115–118
78. Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2965–2971
79. Passauer J, Petrov H, Schleser A. Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study. Nephrol Dial Transplant 2009; 1: 1–7
80. Ponce P, Taborsky P, Vlasak J. Assessment and reduction of fluid overload using a body composition monitor. NDT Plus 2009; 2 (4): 335-336
81. Onofriescu M, Mardare NG, Segall L et al. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol 2012; 44(2): 583-591
82. Tapolyai M, Faludi M, Reti V et al. Dialysis patients fluid overload, antihypertensive medications, and obesity. J ASAIO 2011; 57(6): 511-515
83. Machek P, Jirka T, Moissl U et al. Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 538–544
84. Parmentier SP, Schirutschke H, Schmitt B et al. Influence of peritoneal dialysis solution on measurements of fluid status by bioimpedance spectroscopy (abstract). Int Urol Nephrol 2012; http://www.springerlink.com/content/2v08u83q00u62t18/
85. Rosina J, Vranova J, Remes O et al. Bioimpedance Spectroscopy as a noninvasive method of determination of the hydration status in hemodialysis patients. Acta Mechanica Slovaca 2010; 14 (2): 72-77
86. Cheriex E, Leunissen K, Janssen J et al. Echography of the inferior vena cava is a simple and reliable tool for estimation of «dry weight» in hemodialysis patients. Nephrol Dial Transplant 1989; 4: 563–568
87. Hur E, Gungor O, Musayev O et al. Bioimpedance spectroscopy for the detection of hypervolemia in peritoneal dialysis patients. Adv Perit Dial 2011; 27: 65-70
88. Sipahi S, Hur E, Demirtas S et al. Body composition monitor measurement technique for the detection of volume status in peritoneal dialysis patients: the effect of abdominal fullness. Int Urol Nephrol 2011; 43(4):1195-1199
Review
For citations:
Rakhmatullina L.N., Gurevich K.Y. APPLICATION BIOIMPEDANCE BODY COMPOSITION МОNITOR (BCM) IN CLINICAL PRACTICE IN DIALYSIS PATIENTS (LITERATURE REVIEW). Nephrology (Saint-Petersburg). 2013;17(4):49-57. (In Russ.) https://doi.org/10.24884/1561-6274-2013-17-4-49-57
Views:
546
Email this article 